About UsClinical DevelopmentPartnershipsPatients/ProvidersInvestorsPress and Media

Recent News

Stay Informed

Click to receive news alerts

Our Mission

  • To advance patient treatment in cancer
  • To apply new insights from molecular and cancer biology to understand how to improve the efficacy and safety of cancer therapies
  • To develop and commercialize a diverse portfolio of cancer drugs to address unmet medical needs

PICASSO Trial Program

A Phase III multicenter, international, randomized, double-blinded, placebo-controlled study of doxorubicin plus palifosfamide vs. doxorubicin plus placebo in patients with front-line metastatic soft tissue sarcoma. (PICASSO 3)

Open for Enrollment: Enrollment has commenced for this global Phase III randomized trial of palifosfamide in combination with doxorubicin in subjects with front-line metastatic soft-tissue sarcoma. (PICASSO 3).

Click here for Press Release.


ZIOPHARM  Intrexon

March 7th, 2011

ZIOPHARM and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin in Asia

Click Here for the Press Release

 

  

January 6th, 2011

ZIOPHARM Oncology and Intrexon Announce Worldwide Partnership for Synthetic Biology DNA-based Oncology Therapeutics

Click Here for the Press Release

 



January 20, 2012

ZIOPHARM Oncology Prices Public Offering of Common Stock More

January 19, 2012

ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock More




Video Media Coverage

Forbes.com article
Is Randal J. Kirk Biotech’s Best Investor?
February 22, 2011
More

Forbes.com article
A Biotech Billionaire And His Radical DNA Drug That Kills Cancer From Within
January 7, 2011
More

Forbes.com article
Thornton returns to Ziopharm Oncology
January 4, 2011
More

Businessweek article
July 23, 2007 issue
More

Businessweek article
May 5, 2008 issue
More

Forbes.com article
May 9, 2008 issue
More

ZIO-101 listed as 100 Great Investigational Drugs by R&D Directions More

ZIO-201 listed as 100 Great Investigational Drugs by R&D Directions More

Webcast Events and Presentations

The 30th Annual J.P. Morgan Healthcare Conference
January 11, 2012
Click Here for More Information

The Oppenheimer 22nd Annual Healthcare Conference
December 14, 2011
Click Here for More Information

The 23rd Annual Piper Jaffray Health Care Conference
November 29, 2011
Click Here for More Information

Lazard Capital Markets 8th Annual Healthcare Conference
November 16, 2011
Click Here for More Information

Biotechnology Industry Organization The 10th Annual Bio Investor Forum
October 25, 2011
Click Here for More Information

BioCentury Publications Inc. NewsMakers in the Biotech Industry Conference
October 21, 2011
Click Here for More Information

Jefferies 2011 Global Healthcare Conference
September 28, 2011
Click Here for More Information

JMP Securities Healthcare Conference
September 27, 2011
Click Here for More Information

Rodman & Renshaw Annual Global Investment Conference
September 12, 2011
Click Here for More Information

Ziopharm Investor Day at NASDAQ Marketsite
June 23, 2011
Click Here for More Information